google-site-verification: googlec7193c3de77668c9.html
Saturday , September 5 2026

GLP-1RAs shown to reduce risk of cardiovascular death

[
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed both for Type 2 diabetes and weight loss. These drugs also have shown promise in clinical trials for patients with chronic cardiovascular, kidney, and metabolic diseases. Those studies focused mainly on patients with singular diagnoses, but these conditions often overlap.


Source link

Advertisements

See also  Key protein behind chemotherapy resistance in colorectal cancer identified

Check Also

People affected by cancer need a stronger voice in shaping generative AI for oncology, review finds

[ Credit: Unsplash/CC0 Public Domain Flinders University researchers were part of an international team that …

Children’s suicide-related emergency visits spiked by 74% in the US between 2016–2022

[ Credit: Unsplash/CC0 Public Domain Emergency visits by children with suicide-related crises increased by 74% …

National call to action needed to strengthen primary care pipeline in medical education, argue experts

[ A new paper led by a faculty member at the Hackensack Meridian School of …

Leave a Reply

Available for Amazon Prime